COVID-19 patients. COVID-19, virus identified
Conditions
Interventions
Intervention 1: Intervention group: Vitamin C is made by Osweh Pharmaceutical Company, will be administered 4 grams by injection every 12 hours for 10 days. Intervention 2: Control group: They will no
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Respiratory failure index (RIF) Treated in the ICU
Exclusion criteria
Exclusion criteria: Patients with a history of vitamin C allergy. Patients with asthma due to cardiopulmonary edema Pregnant or lactating women Patients with a survival time of less than 24 hours Patients with a history of end-stage lung disease, end-stage malignant tumor, G-6-PD deficiency, diabetic ketoacidosis, active kidney stone disease, and severe kidney disease Patients who have already enrolled in another clinical trial Patients with a known history of kidney disease, chronic renal failure, or acute renal failure during hospitalization
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The amount of lung involvement in a CT scan. Timepoint: Every 12 hours, Up to 10 days. Method of measurement: According to the radiologist, the appearance of lung involvement and the percentage of lung involvement are measured. | — |
Secondary
| Measure | Time frame |
|---|---|
| Oxygen saturation. Timepoint: Every 12 hours, Up to 10 days. Method of measurement: Observations and clinical examinations.;Respiratory rate. Timepoint: Every 12 hours, Up to 10 days. Method of measurement: Observations and clinical examinations.;Duration of hospitalization. Timepoint: Daily since hospitalization time. Method of measurement: Based on patient records.;Mortality rate. Timepoint: Daily. Method of measurement: Census. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMoloud Balafar
Tabriz University of Medical Sciences
Outcome results
None listed